Grosman et al., 1995 - Google Patents
The human choline acetyltransferase gene encodes two proteinsGrosman et al., 1995
- Document ID
- 4905670369692844868
- Author
- Grosman D
- Lorenzi M
- Trinidad A
- Strauss W
- Publication year
- Publication venue
- Journal of neurochemistry
External Links
Snippet
Both, 2,500‐and 6,000‐nucleotide (nt) mRNAs are generated by alternative splicing of the primary transcript from the human gene for choline acetyltransferase (ChAT), the 68‐kDa enzyme that synthesizes acetylcholine. In vitro translation of cRNA derived from a clone of …
- 102000004169 proteins and genes 0 title abstract description 111
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rossetto et al. | VAMP/synaptobrevin isoforms 1 and 2 are widely and differentially expressed in nonneuronal tissues. | |
| Welcher et al. | A myelin protein is encoded by the homologue of a growth arrest-specific gene. | |
| Otto et al. | Isolation and characterization of cDNAs encoding human brain ankyrins reveal a family of alternatively spliced genes. | |
| Eiden | The cholinergic gene locus | |
| Kordeli et al. | Distinct ankyrin isoforms at neuron cell bodies and nodes of Ranvier resolved using erythrocyte ankyrin-deficient mice. | |
| JP4185512B2 (en) | TGF-β type receptor cDNA and use thereof | |
| KR100828058B1 (en) | Blocking axon growth mediated by NOX receptors | |
| Hu et al. | Characterization of human brain cDNA encoding the general isoform of beta-spectrin. | |
| Stenius et al. | Structure of synaptogyrin (p29) defines novel synaptic vesicle protein. | |
| Krasemann et al. | Induction of antibodies against human prion proteins (PrP) by DNA-mediated immunization of PrP00 mice | |
| Gould et al. | Expression of the brain-type glucose transporter is restricted to brain and neuronal cells in mice | |
| Grosman et al. | The human choline acetyltransferase gene encodes two proteins | |
| Madison et al. | Differential expression of rab3 isoforms in oligodendrocytes and astrocytes | |
| Yamada et al. | Immunohistochemical distribution of the two isoforms of synaphin/complexin involved in neurotransmitter release: localization at the distinct central nervous system regions and synaptic types | |
| WO1998022499A9 (en) | Arretin, a neurite outgrowth modulator, antibodies thereto and uses thereof | |
| WO1998022499A2 (en) | Arretin, a neurite outgrowth modulator, antibodies thereto and uses thereof | |
| US8013118B2 (en) | Lynx polypeptides | |
| Bodden et al. | CRYP‐2: A receptor‐type tyrosine phosphatase selectively expressed by developing vertebrate neurons | |
| US5767252A (en) | Neuronal cell growth factor, Narp | |
| JPH08500246A (en) | Cell growth inhibitor, preparation and use thereof | |
| WO2000042166A2 (en) | Methods and compositions for monitoring cellular processing of epitope-tagged beta-amyloid precursor protein | |
| JPH09194502A (en) | New chondroitin sulfate proteoglycan, its core protein, dna coding the same and antibody to the same | |
| JP2007204473A (en) | Novel chondroitin sulfate proteoglycan, core protein thereof, dna encoding the same, and antibody against the same | |
| EP1367123A1 (en) | Neurotonin and use thereof | |
| US20100034788A1 (en) | Method for diagnosing and treating bone-related diseases |